VanEck Biotech ETF (BBH): ETF
ETF traded on XNAS under symbol BBH. Quoted in usd.
VanEck Biotech ETF
+1.07%$256.17
XNAS:BBHEquity
AUM $523.86M·YTD --·Yield --
XNAS:BBH$256.17+1.07%AUM $523.86MAbout BBH
The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.
Largest holdings
- AMGN Amgen Inc16.77%
- GILD Gilead Sciences Inc14.42%
- VRTX Vertex Pharmaceuticals Inc8.30%
- REGN Regeneron Pharmaceuticals Inc7.53%
- MRNA Moderna Inc7.40%
- IQV Iqvia Holdings Inc4.28%
- NTRA Natera Inc4.22%
- ARGX Argenx Se4.17%
- RVMD Revolution Medicines Inc3.55%
- ILMN Illumina Inc2.99%
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$111,146
Total Return
+$41,146
(+58.8%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$523.86M
NAV$253.50
Premium/Discount+1.05%
Expense Ratio0.35%
Market Cap--
Shares Outstanding--
Inception DateDec. 20, 2011
Fund Details
IssuerVanEck
Asset ClassEquity
Beta--
SectorFinancial Services
DomicileUS
52-Week Range
$178.78$263.74
Current: $256.17
Volume
Volume7.55K
Avg Volume10.53K
Vol/Avg0.72x
30d
15.59K
60d
12.77K
90d
12.71K
Comparable ETFs